New strategy of early surgery for infective endocarditis complicated by intracranial hemorrhage
Surgery Today · 2025
DOI: 10.1007/s00595-024-02964-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Surgery Today, 2025. Verfasst von Shota Hasegawa und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Surgery, Department of Surgery, Kobe University Graduate School of Medicine, 2-5-7, Kusunoki-cho, Chuo-ku, Kobe, 650-0017,…. Hauptthemen laut MEDLINE: Intracranial Hemorrhages, Guanidines, Endocarditis, Cardiac Surgical Procedures. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kobe University.
Abstract (Originalsprache)
Purpose
Early surgery for infective endocarditis with intracranial hemorrhage can cause severe bleeding, which is correlated with an increased mortality. In 2005, we started using nafamostat mesilate and low-dose heparin as anticoagulants during cardiopulmonary bypass for early surgery. The outcomes of this strategy have been reviewed.
Methods
All patients who underwent cardiac surgery for active infective endocarditis with intracranial hemorrhage between 2005 and 2023 were evaluated.
Results
There were 23 consecutive patients (median age 62 years old). Ten patients (43%) had neurologic deficits. The indication for early surgery in most patients was the presence of mobile vegetation or existing embolic events (18 of 23, 78%). No complications were associated with cardiopulmonary bypass. The median interval between the diagnosis and surgery was two days. There was 1 early death (4%) due to sepsis. There was no exacerbation of intracranial hemorrhage. One patient had new ectopic microbleeds without deterioration of neurologic findings. One patient had a new-onset cerebral infarction with neurologic deficits. None of the patients exhibited neurologic deterioration. The median follow-up duration was 26 months. overall survival was 90.7% after 5 years.
Conclusions
Our strategy of using nafamostat mesilate enabled us to safely perform early surgery in patients with intracranial hemorrhage without hemorrhage exacerbation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cardiovascular Surgery, Department of Surgery, Kobe University Graduate School of Medicine, 2-5-7, Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan.
- Division of Cardiovascular Surgery, Department of Surgery, Kobe University Graduate School of Medicine, 2-5-7, Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan. kokada@med.kobe-u.ac.jp.
Förderung
- Kobe University
Zitieren
APA
Hasegawa, S., Takahashi, H., Yamanaka, K., & Okada, K. (2025). New strategy of early surgery for infective endocarditis complicated by intracranial hemorrhage. Surgery Today. https://doi.org/10.1007/s00595-024-02964-1
Vancouver
Hasegawa S, Takahashi H, Yamanaka K, Okada K. New strategy of early surgery for infective endocarditis complicated by intracranial hemorrhage. Surgery Today. 2025. doi:10.1007/s00595-024-02964-1
BibTeX
@article{Hasegawa2025,
author = {Hasegawa, Shota and Takahashi, Hiroaki and Yamanaka, Katsuhiro and Okada, Kenji},
title = {New strategy of early surgery for infective endocarditis complicated by intracranial hemorrhage},
journal = {Surgery Today},
year = {2025},
doi = {10.1007/s00595-024-02964-1}
}
EUVIMED